Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?.

Author: Yeon Mok OH ¹
Author Information

1. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ymoh55@amc.seoul.kr
Publication Type:Editorial
MeSH: Pulmonary Disease, Chronic Obstructive*
From:Tuberculosis and Respiratory Diseases 2017;80(1):93-94
CountryRepublic of Korea
Language:English
Abstract: No abstract available.